Literature DB >> 29687226

Physical Stability of Amorphous Solid Dispersions: a Physicochemical Perspective with Thermodynamic, Kinetic and Environmental Aspects.

Xia Lin1, Yang Hu1, Lei Liu1, Lili Su1, Na Li1, Jing Yu1, Bo Tang2, Ziyi Yang3.   

Abstract

PURPOSE: Amorphous solid dispersions (ASDs) have been widely used in the pharmaceutical industry for solubility enhancementof poorly water-soluble drugs. The physical stability, however, remainsone of the most challenging issues for the formulation development.Many factors can affect the physical stability via different mechanisms, and therefore an in-depth understanding on these factors isrequired.
METHODS: In this review, we intend to summarize the physical stability of ASDsfrom a physicochemical perspective whereby factors that can influence the physical stability areclassified into thermodynamic, kinetic and environmental aspects.
RESULTS: The drug-polymer miscibility and solubility are consideredas the main thermodynamicfactors which may determine the spontaneity of the occurrence of the physical instabilityof ASDs. Glass-transition temperature,molecular mobility, manufacturing process,physical stabilityof amorphous drugs, and drug-polymerinteractionsareconsideredas the kinetic factors which areassociated with the kinetic stability of ASDs on aging. Storage conditions including temperature and humidity could significantly affect the thermodynamicand kineticstabilityof ASDs.
CONCLUSION: When designing amorphous solid dispersions, it isrecommended that these thermodynamic, kinetic and environmental aspects should be completely investigatedand compared to establish rationale formulations for amorphous solid dispersions with high physical stability.

Entities:  

Keywords:  amorphous solid dispersions; kinetic stability; physical stability; thermodynamic stability

Mesh:

Substances:

Year:  2018        PMID: 29687226     DOI: 10.1007/s11095-018-2408-3

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  113 in total

1.  Thermodynamic phase behaviour of indomethacin/PLGA formulations.

Authors:  Anke Prudic; Anna-Katharina Lesniak; Yuanhui Ji; Gabriele Sadowski
Journal:  Eur J Pharm Biopharm       Date:  2015-03-16       Impact factor: 5.571

2.  An investigation into the role of polymeric carriers on crystal growth within amorphous solid dispersion systems.

Authors:  Yiwei Tian; David S Jones; Gavin P Andrews
Journal:  Mol Pharm       Date:  2015-03-06       Impact factor: 4.939

Review 3.  The Application of Modeling and Prediction to the Formation and Stability of Amorphous Solid Dispersions.

Authors:  Kevin DeBoyace; Peter L D Wildfong
Journal:  J Pharm Sci       Date:  2017-04-05       Impact factor: 3.534

4.  Molecular indicators of surface and bulk instability of hot melt extruded amorphous solid dispersions.

Authors:  Ziyi Yang; Kathrin Nollenberger; Jessica Albers; Duncan Craig; Sheng Qi
Journal:  Pharm Res       Date:  2014-10-01       Impact factor: 4.200

Review 5.  The role of the carrier in the formulation of pharmaceutical solid dispersions. Part I: crystalline and semi-crystalline carriers.

Authors:  Tu Van Duong; Guy Van den Mooter
Journal:  Expert Opin Drug Deliv       Date:  2016-06-20       Impact factor: 6.648

6.  Solubility parameter of selected sulfonamides.

Authors:  C Sunwoo; H Eisen
Journal:  J Pharm Sci       Date:  1971-02       Impact factor: 3.534

7.  Effect of glass transition temperature on the stability of lyophilized formulations containing a chimeric therapeutic monoclonal antibody.

Authors:  S P Duddu; P R Dal Monte
Journal:  Pharm Res       Date:  1997-05       Impact factor: 4.200

8.  Evaluation of drug-polymer miscibility in amorphous solid dispersion systems.

Authors:  Alfred C F Rumondor; Igor Ivanisevic; Simon Bates; David E Alonzo; Lynne S Taylor
Journal:  Pharm Res       Date:  2009-09-22       Impact factor: 4.200

9.  The influence of drug physical state on the dissolution enhancement of solid dispersions prepared via hot-melt extrusion: a case study using olanzapine.

Authors:  Maria Fátima Pina; Min Zhao; João F Pinto; João J Sousa; Duncan Q M Craig
Journal:  J Pharm Sci       Date:  2014-04       Impact factor: 3.534

10.  Amorphous-Amorphous Phase Separation in API/Polymer Formulations.

Authors:  Christian Luebbert; Fabian Huxoll; Gabriele Sadowski
Journal:  Molecules       Date:  2017-02-15       Impact factor: 4.411

View more
  18 in total

1.  Development and Evaluation of Cocoa Butter Taste Masked Ibuprofen Using Supercritical Carbon Dioxide.

Authors:  Rana Obaidat; Haneen Aleih; Hadeia Mashaqbeh; Bashar Altaani; Mo'tasem M Alsmadi; Mohammad Alnaief
Journal:  AAPS PharmSciTech       Date:  2021-03-14       Impact factor: 3.246

Review 2.  Hot-Melt Extrusion: a Roadmap for Product Development.

Authors:  Marta F Simões; Rui M A Pinto; Sérgio Simões
Journal:  AAPS PharmSciTech       Date:  2021-06-17       Impact factor: 3.246

Review 3.  Drug-Rich Phases Induced by Amorphous Solid Dispersion: Arbitrary or Intentional Goal in Oral Drug Delivery?

Authors:  Kaijie Qian; Lorenzo Stella; David S Jones; Gavin P Andrews; Huachuan Du; Yiwei Tian
Journal:  Pharmaceutics       Date:  2021-06-15       Impact factor: 6.321

Review 4.  Quality-by-design in hot melt extrusion based amorphous solid dispersions: An industrial perspective on product development.

Authors:  Arun Butreddy; Suresh Bandari; Michael A Repka
Journal:  Eur J Pharm Sci       Date:  2020-11-28       Impact factor: 4.384

5.  A Novel Protocol Using Small-Scale Spray-Drying for the Efficient Screening of Solid Dispersions in Early Drug Development and Formulation, as a Straight Pathway from Screening to Manufacturing Stages.

Authors:  Aymeric Ousset; Rosanna Chirico; Florent Robin; Martin Alexander Schubert; Pascal Somville; Kalliopi Dodou
Journal:  Pharmaceuticals (Basel)       Date:  2018-08-27

6.  Use of Terahertz-Raman Spectroscopy to Determine Solubility of the Crystalline Active Pharmaceutical Ingredient in Polymeric Matrices during Hot Melt Extrusion.

Authors:  Ecaterina Bordos; Muhammad T Islam; Alastair J Florence; Gavin W Halbert; John Robertson
Journal:  Mol Pharm       Date:  2019-09-09       Impact factor: 4.939

7.  Commentary: Considerations in the Measurement of Glass Transition Temperatures of Pharmaceutical Amorphous Solids.

Authors:  Ann Newman; George Zografi
Journal:  AAPS PharmSciTech       Date:  2019-12-17       Impact factor: 3.246

Review 8.  Overview of Extensively Employed Polymeric Carriers in Solid Dispersion Technology.

Authors:  Athira R Nair; Yarlagadda Dani Lakshman; Vullendula Sai Krishna Anand; K S Navya Sree; Krishnamurthy Bhat; Swapnil J Dengale
Journal:  AAPS PharmSciTech       Date:  2020-11-08       Impact factor: 3.246

9.  Impact of HPMCAS on the Dissolution Performance of Polyvinyl Alcohol Celecoxib Amorphous Solid Dispersions.

Authors:  Marius Monschke; Karl G Wagner
Journal:  Pharmaceutics       Date:  2020-06-11       Impact factor: 6.321

10.  Processing of Polyvinyl Acetate Phthalate in Hot-Melt Extrusion-Preparation of Amorphous Solid Dispersions.

Authors:  Marius Monschke; Kevin Kayser; Karl G Wagner
Journal:  Pharmaceutics       Date:  2020-04-09       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.